Literature DB >> 11027445

Serum lactate dehydrogenase isoenzyme 1 as a prognostic predictor for metastatic testicular germ cell tumours.

F E von Eyben, E L Madsen, F Liu, R Amato, H Fritsche.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11027445      PMCID: PMC2363593          DOI: 10.1054/bjoc.2000.1449

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  5 in total

1.  Quantitative Characterization of the Exposure-Response Relationship for Cancer Immunotherapy: A Case Study of Nivolumab in Patients With Advanced Melanoma.

Authors:  X Wang; Y Feng; G Bajaj; M Gupta; S Agrawal; A Yang; J-S Park; B Lestini; A Roy
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2016-12-26

2.  Correlation analysis of serum cystatin C, uric acid and lactate dehydrogenase levels before chemotherapy on the prognosis of small-cell lung cancer.

Authors:  Haocheng Wang; Dongfeng Shan; Ya Dong; Xue Yang; Linwei Zhang; Zhuang Yu
Journal:  Oncol Lett       Date:  2020-11-25       Impact factor: 2.967

3.  Utility of serum and salivary lactate dehydrogenase and uric acid levels as a diagnostic profile in oral squamous cell carcinoma patients.

Authors:  G Anitha; K Vinod Kumar; Gururaj Deshpande; M Nagaraj; Veerbhadra Kalyani
Journal:  J Oral Maxillofac Pathol       Date:  2022-06-28

4.  Overall survival of cancer patients with serum lactate dehydrogenase greater than 1000 IU/L.

Authors:  Rujiao Liu; Jun Cao; Xiang Gao; Jian Zhang; Leiping Wang; Biyun Wang; Lin Guo; Xichun Hu; Zhonghua Wang
Journal:  Tumour Biol       Date:  2016-08-10

5.  Prognostic value of D-lactate dehydrogenase in patients with clear cell renal cell carcinoma.

Authors:  Yue Wang; Gaoxiang Li; Fangning Wan; Bo Dai; Dingwei Ye
Journal:  Oncol Lett       Date:  2018-05-22       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.